surmount-1 tirzepatide weight loss nondiabetic FDA Grants a New Indication for Obesity Management SURMOUNT-MAINTAIN: Drop Your Tirzepatide Dose?

Gastroenterology 132, 21312157

1 Upon analysis, results suggested the placebo-adjusted systolic blood pressure changes from baseline were 7.4 (95% CI, 10.0 to 4.7) mmHg, 10.6 (95% CI, 13.2 to 8.0) mmHg , and 8.0 (95% CI, 10.6 to 5.4) mmHg for tirzepatide 5, 10, and 15 mg, respectively

If your insurance covers Wegovy or Zepbound, you may only pay a co-pay on top of the membership potentially making Ro cheaper

I wish we just eat the proteins

To further assess the adverse profile of GLP-1MK-801, we performed a series of complementary studies in mice and rats

Patients are sold home treatment injections or do-it-yourself packs